Follow this preprint
Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantitation of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals
Farah M. Shurrab, Nadin Younes, Duaa W. Al-Sadeq, Hamda Qotba, Laith J. Abu-Raddad, View ORCID ProfileGheyath K. Nasrallah
doi: https://doi.org/10.1101/2022.01.04.22268717
Now published in International Journal of Infectious Diseases doi: 10.1016/j.ijid.2022.02.052
Farah M. Shurrab
1Biomedical Research Center, Qatar University, 2713 Doha, Qatar
2Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, 2713 Doha, Qatar
Nadin Younes
1Biomedical Research Center, Qatar University, 2713 Doha, Qatar
2Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, 2713 Doha, Qatar
Duaa W. Al-Sadeq
1Biomedical Research Center, Qatar University, 2713 Doha, Qatar
3College of Medicine, Member of QU Health, Qatar University, 2713 Doha, Qatar
Hamda Qotba
4Department of Clinical Research, Primary Health Care Centers, 26555, Doha, Qatar
Laith J. Abu-Raddad
5Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation—Education City, 24144 Doha, Qatar
6World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, 24144 Doha, Qatar
7Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA
Gheyath K. Nasrallah
1Biomedical Research Center, Qatar University, 2713 Doha, Qatar
2Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, 2713 Doha, Qatar

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted January 05, 2022.
Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantitation of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals
Farah M. Shurrab, Nadin Younes, Duaa W. Al-Sadeq, Hamda Qotba, Laith J. Abu-Raddad, Gheyath K. Nasrallah
medRxiv 2022.01.04.22268717; doi: https://doi.org/10.1101/2022.01.04.22268717
Now published in International Journal of Infectious Diseases doi: 10.1016/j.ijid.2022.02.052
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (417)
- Allergy and Immunology (739)
- Anesthesia (216)
- Cardiovascular Medicine (3168)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13136)
- Forensic Medicine (17)
- Gastroenterology (878)
- Genetic and Genomic Medicine (4962)
- Geriatric Medicine (457)
- Health Economics (761)
- Health Informatics (3124)
- Health Policy (1114)
- Hematology (417)
- HIV/AIDS (986)
- Medical Education (462)
- Medical Ethics (121)
- Nephrology (511)
- Neurology (4715)
- Nursing (250)
- Nutrition (699)
- Oncology (2431)
- Ophthalmology (691)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (314)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1263)
- Primary Care Research (535)
- Public and Global Health (7281)
- Radiology and Imaging (1629)
- Respiratory Medicine (952)
- Rheumatology (468)
- Sports Medicine (409)
- Surgery (527)
- Toxicology (66)
- Transplantation (225)
- Urology (195)